• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION WATCHMAN FLX LEFT ATRIAL APPENDAGE CLOSURE DEVICE WITH DELIVERY SYSTEM; SYSTEM, APPENDAGE CLOSURE, LEFT ATRIAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION WATCHMAN FLX LEFT ATRIAL APPENDAGE CLOSURE DEVICE WITH DELIVERY SYSTEM; SYSTEM, APPENDAGE CLOSURE, LEFT ATRIAL Back to Search Results
Model Number 10390
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Low Blood Pressure/ Hypotension (1914); Perforation (2001); Tachycardia (2095); Cardiac Tamponade (2226); Pericardial Effusion (3271)
Event Date 10/19/2022
Event Type  Injury  
Event Description
It was reported that there was a pericardial effusion.A left atrial appendage (laa) closure procedure was being performed.A watchman fxd curve access system (was) was positioned and a 20mm watchman flx laa closure device & delivery system (wds) were used.The physician positioned the was in the laa of the patient and then inserted the wds.While deploying the closure device in the laa the physician felt the wds shift.The closure device was deployed in an acceptable position.After this deployment it was noted that the patients blood pressure dropped, and they had an elevated heart rate.A transesophageal echocardiogram (tee) was performed which showed that there was a pericardial effusion with cardiac tamponade around the anterior and inferior left and right ventricle.The patient blood pressure continued to drop, so was given medication to treat this.The physician gave the patient protamine and performed a pericardiocentesis.1175ml of fluid was drained from the effusion and the patient was given 3 units of blood.A cardioversion procedure was performed twice before successfully helping the patient return to a sinus rhythm.The procedure was continued with the closure device released in the laa of the patient.The patients blood pressure improved, the pericardial effusion resolved, and the patient became hemodynamically stable.The patient was taken to the icu where they were monitored.The patient made a full recovery and was discharged home the next day with no other consequences or complications that were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
WATCHMAN FLX LEFT ATRIAL APPENDAGE CLOSURE DEVICE WITH DELIVERY SYSTEM
Type of Device
SYSTEM, APPENDAGE CLOSURE, LEFT ATRIAL
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
jay johnson
4100 hamline ave n
arden hills, MN 55112
6515810888
MDR Report Key15672652
MDR Text Key302404999
Report Number2124215-2022-43416
Device Sequence Number1
Product Code NGV
UDI-Device Identifier08714729860488
UDI-Public08714729860488
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 10/26/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number10390
Device Catalogue Number10390
Device Lot Number0029143185
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 10/19/2022
Initial Date FDA Received10/26/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/31/2022
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age71 YR
Patient SexMale
-
-